A Case Example: Reversing Anticoagulant Dabigatran with Idarucizumab
The Case A 75-year-old man presents to your emergency department via paramedics. His transport time was about…
Idarucizumab
-
A Case Example: Reversing Anticoagulant Dabigatran with Idarucizumab
The Case A 75-year-old man presents to your emergency department via paramedics. His transport time was about... -
New-Drug Details: Reversing Anticoagulant Dabigatran with Idarucizumab
Idarucizumab (Praxbind) is the first and only specific reversal agent for a novel oral anticoagulant (NOAC) approved... -
Pearls from Emergency Medicine Literature on Pulmonary Problems, Bleeding, Evaluating Pediatric Injuries, and More
Last month, I highlighted some of the most impactful, talked-about, or interesting articles published across the spectrum...
New-Drug Details: Reversing Anticoagulant Dabigatran with Idarucizumab
Idarucizumab (Praxbind) is the first and only specific reversal agent for a novel oral anticoagulant (NOAC) approved…
Pearls from Emergency Medicine Literature on Pulmonary Problems, Bleeding, Evaluating Pediatric Injuries, and More
Last month, I highlighted some of the most impactful, talked-about, or interesting articles published across the spectrum…
Results Confirm Idarucizumab’s Ability to Restore Clotting in Dabigatran Recipients
The blood thinning effects of dabigatran (Pradaxa) can be quickly and reliably reversed by giving idarucizumab (Praxbind)…